-
GP Test Cyp 250
Geneza Pharmaceuticals
1 x 10 ml » 250 mg/ml
General information:
Manufacturer: Geneza Pharmaceuticals
Substance: Testosterone Cypionate
Pack: 10 ml vial (250 mg/ml)
Active Life: 15-16 days
Drug Class: Anabolic/Androgenic Steroid (for injection)
Average Dose: Men 250-1000 mg/week
Acne: Yes
Water Retention: Yes, high
High Blood Pressure: Yes
Liver Toxic: Low, except in mega dosages
Aromatization:Yes, high
DHT Conversion: Yes, high
Decrease HPTA function: Yes, severe
American athletes have a long and fond relationship with
Testosterone Cypionate.
While Testosterone enanthate is manufactured widely throughout the
world, cypionate seems to be almost exclusively an American item. It is
therefore not surprising that American athletes particularly favor this
testosterone ester. But many claim this is not just a matter of simple
pride, often swearing cypionate to be a superior product, providing a
bit more of a "kick" than enanthate. At the same time it is said to
produce a slightly higher level of water retention, but not enough for
it to be easily discerned. Of course when we look at the situation
objectively, we see these two steroids are really interchangeable, and
cypionate is not at all superior. Both are long acting oil-based
injectables, which will keep testosterone levels sufficiently elevated
for approximately two weeks. Enanthate may be slightly better in terms
of testosterone release, as this ester is one carbon atom lighter than
cypionate (remember the ester is calculated in the steroids total
milligram weight). The difference is so insignificant however that no
one can rightly claim it to be noticeable (we are maybe talking a few
milligrams per shot). Regardless, cypionate came to be the most popular
testosterone ester on the U.S. black market for a very long time
As with all testosterone injectables, one can expect a considerable
gain in muscle mass and strength during a cycle. Since testosterone
readliy converts to estrogen, the mass gained from this drug is likely
to be accompanied by quite a bit of water retention. The resulting loss
of definition of course makes cypionate a very poor choice for dieting
or cutting phases. The excess level of estrogen brought about by this
drug can also cause one to develop gynecomastia rather quickly. Should
one notice an uncomfortable soreness, swelling or lump under the
nipple, an ancillary drug like Nolvadex should be added immediately.
This will minimize the effect of estrogen greatly, making the steroid
much more tolerable to use. The powerful anti-aromatases Arimidex,
Femara, or Aromasin are yet a better choice. Those who have a known
sensitivity to estrogen may find it more beneficial to use ancillary
drugs like Nolvadex and Proviron from the onset of the cycle, in order
to prevent estrogen related side effects before they become apparent.
Since testosterone is the primary male androgen, we should also expect
to see pronounced androgenic side effects with this drug. Much
intensity is related to the rate in which the body converts
testosterone into dihydrotestosterone (DHT). This, as you know, is the
devious metabolite responsible for the high prominence of androgenic
side effects associated with testosterone use. This includes the
development of oily skin, acne, body/facial hair growth and male
pattern balding. Those worried that they may have a genetic
predisposition toward male pattern baldness may wish to avoid
testosterone altogether. Others opt to add the ancillary drug
Proscar/Propecia, that prevents the conversion of testosterone to
dihydrotestosterone. This can greatly reduce the chance for running
into a hair loss problem, and will probably lower the intensity of
other androgenic side effects. Although active in the body for much
longer time, cypionate is injected on a weekly or bi-weekly basis in
order to maintain stable blood levels. At a dosage of 250mg to 800mg
per week we should certainly see dramatic results. It is interesting to
note that while a large number of other steroidal compounds have been
made available since testosterone injectables, they are still
considered to be the dominant bulking agents among bodybuilders. There
is little argument that these are among the most powerful mass drugs.
When taking dosages above 800-1000mg per week there is little doubt
that water retention will come to be the primary gain, far outweighing
the new mass accumulation. The practice of "megadosing" is therefore
inefficient, especially when we take into account the typical high cost
of steroids today.
It is also important to remember that the use of an injectable
testosterone will quickly suppress endogenous testosterone production.
It is therefore mandatory to complete a proper post cycle therapy,
constisting of HCG and Clomid or Nolvadex at the conclusion of a cycle.
This should help the user avoid a strong "crash" due to hormonal
imbalance, which can strip away much of the new muscle mass and
strength. This is no doubt the reason why many athletes claim to be
very disappointed with the final result of steroid use, as there is
often only a slight permanent gain if anabolics are discontinued
incorrectly. Of course we cannot expect to retain every pound of new
bodyweight after a cycle. This is especially true whenever we are
withdrawing a strong (aromatizing) androgen like testosterone, as a
considerable drop in weight (and strength) is to be expected as
retained water is excreted. This should not be of much concern; instead
the user should focus on ancillary drug therapy so as to preserve the
solid mass underneath. Another way athletes have found to lessen the
"crash", is to first replace the testosterone with a milder anabolic
like Deca-Durabolin. This steroid is administered alone, at a typical
dosage (200-400mg per week), for the following month or two. In this
"stepping down" procedure the user is attempting to turn the watery
bulk of a strong testosterone into the more solid muscularity we see
with nandrolone preparations. In many instances this practice proves to
be very effective. Of course we must remember to still administer
ancillary drugs at the conclusion, as endogenous testosterone
production will not be rebounding during the Deca therapy.